Table 1.
Risk factors for incidence of nephrolithiasis in free-living subjects from southern Italy over 40 years old
| p | HR | 95% CI | ||
|---|---|---|---|---|
| Osteoporosis diagnosis (y/n) | 0.04 | 1.33 | 1.01 | 1.74 |
| Age (years) | 0.02 | 0.99 | 0.98 | 1.00 |
| Sex (m/f) | 0.52 | 0.87 | 0.56 | 1.34 |
| BMI (Kg/m2) | 0.22 | 0.99 | 0.97 | 1.01 |
| Osteoporosis treatment (y/n) | 0.39 | 1.15 | 0.84 | 1.56 |
| Current smokers (y/n) | 0.18 | 1.17 | 0.93 | 1.48 |
| Previous smokers (y/n) | 0.68 | 1.08 | 0.73 | 1.60 |
Osteoporosis diagnosis was rendered according to the World Health Organization (WHO) diagnostic criteria: T-score value measured by Dual-Energy X-ray absorptiometry ≤ − 2.5 in the lumbar spine, total hip or femoral neck [14]. HR: hazard ratio. CI: confidence interval. BMI: body mass index. Osteoporosis treatment: current or previous single or combinate use of calcium salts, vitamin D and analogues, selective estrogenic receptor modulators, bisphosphonates, teriparatide, strontium ranelate, or denosumab
Y/n yes or not. M/f male or female